Regulations.gov document
PSG_215383 - Draft Guidance on Belzutifan)
Other · FDA-2007-D-0369 · posted May 19, 2023
Key facts
| Document ID | FDA-2007-D-0369-0870 |
|---|---|
| Title | PSG_215383 - Draft Guidance on Belzutifan) |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2007-D-0369 |
| Posted | May 19, 2023 |
| Comment period opens | May 19, 2023 |
| Comments due | Jul 19, 2023 |
At a glance
- No Open for comment
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: